Mats Sundgren, PhD

home / authors / mats-sundgren-phd

An advisor in health data strategy for industry and academia.

Articles

Scaling eSource-Enabled Clinical Trials: Hospital Perspectives

Scaling eSource-Enabled Clinical Trials: Hospital Perspectives

Mats Sundgren, PhD;Sarah Burge;Lee Andrews II;Matthew Bush;Angela Fritsche;Felix Nensa;Joseph Lengfellner
April 9th 2025

The challenges, opportunities, and strategic outlook for oncology research centers.

Harnessing Unstructured Data and Hospital Interoperability

Harnessing Unstructured Data and Hospital Interoperability

Mats Sundgren, PhD;Rohit Mistry;Gabriel Maeztu
November 15th 2024

The potential of next-generation platforms in transforming patient recruitment.

Streamlining Clinical Trials with eSource: Insights from MSK

Streamlining Clinical Trials with eSource: Insights from MSK

Mats Sundgren, PhD;Gynet Santiago;Joseph Lengfellner
August 19th 2024

A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.

eSource Interoperability Between EHR and EDC

eSource Interoperability Between EHR and EDC

Mats Sundgren, PhD;Wai Keong Wong, PhD, FRCPath, MRCP;Nausheen Saleem;Sarah Taylor ;Lars Fransson;Nick Collins;David Gustafsson;Mikael Forsby;Richard Yeatman
August 14th 2023

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.

Advances in eSource Interoperability Between EHR and EDC

Advances in eSource Interoperability Between EHR and EDC

Mats Sundgren, PhD
December 30th 2022

How evidence generated by the latest IgniteData ‘real-setting’ pilot study supports the case for clinical trial transformation.

Innovations in Data Capture Transforming Trial Delivery

Innovations in Data Capture Transforming Trial Delivery

Mats Sundgren, PhD;Nadir Ammour, MBA, DMD ;Dan Hydes;Dipak Kalra;Richard Yeatman
August 12th 2021

Advances in technology open door for improved EHR to EDC transfer process.

Using Real-World Data in Patient Recruitment

Using Real-World Data in Patient Recruitment

Mats Sundgren, PhD;Kaj Stenlöf MD, PhD;Lollo Eriksson, PhD
April 15th 2021

Growing availability of RWD leads new drug development process.

Latest Updated Articles

Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: February 13th 2025 | Updated: March 4th 2025
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Accelerate Inclusive Enrollment and Delivery with Lightship
Published: February 19th 2025 | Updated: February 26th 2025
Accelerate Inclusive Enrollment and Delivery with Lightship
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: May 8th 2025 | Updated: May 21st 2025
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: February 3rd 2025 | Updated: May 21st 2025
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
Published: February 3rd 2025 | Updated: May 21st 2025
Data-Driven Insights can Optimize Clinical Trial Site Selection
Published: February 3rd 2025 | Updated: May 21st 2025
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation
© 2025 MJH Life Sciences

All rights reserved.